Get started
222

EUBIOLOGICS CO., LTD.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

206650 chart


Full chart

Key stats


Market capitalization
‪480.43 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−50 KRW
Net income (FY)
‪−13.88 B‬ KRW
Revenue (FY)
‪69.37 B‬ KRW
Shares float
‪27.99 M‬
Beta (1Y)
0.62

Employees


Employees (FY)
321
Change (1Y)
+7 +2.23%
Revenue / Employee (1Y)
‪165.96 K‬ KRW
Net income / Employee (1Y)
‪−33.21 K‬ KRW

About EUBIOLOGICS CO., LTD.


Sector
Health Technology
CEO
Yeong-Ok Baek
Headquarters
Seoul
Website
eubiologics.com
Founded
2010
ISIN
KR7206650004
FIGI
BBG00F90XZ93
EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. It offers comprehensive contract research organization and contract manufacturing organization services. Its products include Euvichol, oral cholera vaccine, enteric infection vaccine, and anti-cancer vaccine. The company was founded on March 10, 2010 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

206650 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 206650 is 13,000 KRW — it has increased by 0.61% in the past 24 hours. Watch EUBIOLOGICS CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange EUBIOLOGICS CO., LTD. stocks are traded under the ticker 206650.
206650 stock has fallen by −13.38% compared to the previous week, the month change is a 3.53% rise, over the last year EUBIOLOGICS CO., LTD. has showed a 41.30% increase.
We've gathered analysts' opinions on EUBIOLOGICS CO., LTD. future price: according to them, 206650 price has a max estimate of 15,000.00 KRW and a min estimate of 15,000.00 KRW. Watch 206650 chart and read a more detailed EUBIOLOGICS CO., LTD. stock forecast: see what analysts think of EUBIOLOGICS CO., LTD. and suggest that you do with its stocks.
206650 reached its all-time high on May 13, 2021 with the price of 61,500 KRW, and its all-time low was 3,570 KRW and was reached on Apr 12, 2017. View more price dynamics on 206650 chart.
See other stocks reaching their highest and lowest prices.
206650 stock is 3.92% volatile and has beta coefficient of 0.62. Track EUBIOLOGICS CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is EUBIOLOGICS CO., LTD. there?
Today EUBIOLOGICS CO., LTD. has the market capitalization of ‪480.43 B‬, it has decreased by −8.71% over the last week.
Yes, you can track EUBIOLOGICS CO., LTD. financials in yearly and quarterly reports right on TradingView.
EUBIOLOGICS CO., LTD. revenue for the last quarter amounts to ‪32.10 B‬ KRW, despite the estimated figure of ‪32.10 B‬ KRW. In the next quarter, revenue is expected to reach ‪46.50 B‬ KRW.
206650 net income for the last quarter is ‪16.09 B‬ KRW, while the quarter before that showed ‪−1.59 B‬ KRW of net income which accounts for ‪1.11 K‬% change. Track more EUBIOLOGICS CO., LTD. financial stats to get the full picture.
No, 206650 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 321.00 employees. See our rating of the largest employees — is EUBIOLOGICS CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUBIOLOGICS CO., LTD. EBITDA is ‪36.70 B‬ KRW, and current EBITDA margin is 24.32%. See more stats in EUBIOLOGICS CO., LTD. financial statements.
Like other stocks, 206650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUBIOLOGICS CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUBIOLOGICS CO., LTD. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUBIOLOGICS CO., LTD. stock shows the neutral signal. See more of EUBIOLOGICS CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.